Health Impact Fund

The Health Impact Fund is a revolutionary proposal to make new medicines accessible for all.

Facebook:

Website:

[Health Impact Fund @HealthImpact]

Health Impact Fund: Making New Medicines available to everyone https://t.co/py2BWhu81f via @YouTube

[Aidan Hollis 💚 @aidanhollis]

In this way, firms would be rewarded according to the health impact of their drugs rather than the volumes they sell. In fact, part of the idea is that the firms would be obliged to sell their drugs at or below cost price — so that their remuneration would be purely value-based.

[Aidan Hollis 💚 @aidanhollis]

“The share that each drug would receive would be based on an evaluation of the drug’s overall impact on global health. Those drugs that contribute most to global health would receive the greatest rewards from the pool.

[Aidan Hollis 💚 @aidanhollis]

“One proposed approach to co-ordination is the Health Impact Fund (HIF). This would be a government-funded agency that offers annual rewards pools, from which new drugs would receive a share.

[Aidan Hollis 💚 @aidanhollis]

@larryroope considers how new payment models can work to incentivize new antibiotics for world #AMR week https://t.co/OdQbHl0hjl

[Health Impact Fund @HealthImpact]

https://t.co/DX8iKbYTOi

[Health Impact Fund @HealthImpact]

https://t.co/ntDgNksx7Q We agree with Sen Bernie Sanders: "No one should die or suffer unnecessarily because they cannot afford a prescription drug which costs a few cents or a few dollars to manufacture." But what's the solution?

[Health Impact Fund @HealthImpact]

The Health Impact Fund model doesn't rely on open source drug development or "standing up to the industry", as Sen. Sanders proposes. Instead, it is about designing the incentives for industry to deliver what society values. Please check it out and see why this just makes sense!

[Health Impact Fund @HealthImpact]

Le Monde in English: We propose a publicly-financed international Health Impact Fund to reduce unequal access to medicines! @Thaliaarawi, Jacques Attalie, @ChristophBenn, @aidanhollis, @XavierJaravel, @EvaJoly, Zeke Ngcobo, @ThomasPogge, and Victor Serre.

[Health Impact Fund @HealthImpact]

Le Monde: nous proposons un fonds d'impact sanitaire, pour améliorer l'accès aux médicaments en Afrique et partout -- @Thaliaarawi Jacques Attalie, @ChristophBenn, @aidanhollis, @XavierJaravel , @EvaJoly, Zeke Ngcobo, @ThomasPogge, et Victor Serre.
https://t.co/lqZLIgudKA

[Health Impact Fund @HealthImpact]

Health Impact Fund oped in Le Monde by @Thaliaarawi Jacques Attalie, @ChristophBenn, @aidanhollis, @XavierJaravel , @EvaJoly, Zeke Ngcobo, @ThomasPogge, and Victor Serre. https://t.co/rYbzM7bJ33

[Health Impact Fund @HealthImpact]

Health Impact Fund oped in Le Monde by @Thaliaarawi Jacques Attalie, @ChristophBenn, @aidanhollis, @XavierJaravel , @EvaJoly, Zeke Ngcobo, @ThomasPogge, and Victor Serre. https://t.co/rYbzM7bJ33

[Health Impact Fund @HealthImpact]

Our sister organization, Africa Health and Economic Transformation Initiative (https://t.co/0unJ0u2Gmu) has just been very successfully launched in Kigali.
Its first aim is the Ubuntu Health Impact Pilot to improve access to medicines in Africa.
https://t.co/Z4VlkuHtWi

[Health Impact Fund @HealthImpact]

Sir Michael was an inspiration. He was generous and thoughtful. As head of NICE he showed enormous bravery in making hard decisions, and made it the leading HTA organization in the world. His wisdom on our advisory board will be deeply missed.

[Crowd Funded Cures @CrowdFundedCure]

We are building #DeSci Impact Market for Public Good Medicines (eg generic ketamine to treat depression, fluvoxamine to treat Covid, keto diet to treat cancer) modelled on scaled down version of @HealthImpact Fund. Jump on our Discord to join us 🍄💊✊🏼https://t.co/h6T5CR1xla

[Health Impact Fund @HealthImpact]

Fantastic!
https://t.co/o9nlyyrsf0

[Crowd Funded Cures @CrowdFundedCure]

We are building a DeSci Impact Market for Public Good Medicines (eg generic ketamine to treat depression, fluvoxamine to treat Covid, keto diet to treat cancer) modelled on scaled down version of @HealthImpact Fund. Interested? Jump on our Discord 🍄🔬https://t.co/h6T5CQJVWA

[Health Impact Fund @HealthImpact]

This is a really excellent analysis of the challenges of the "last mile" in health. And it's why the the Health Impact Fund is important.

Innovation alone is not enough. We need there to be rewards for making sure that medicines reach the people who need them.

[Matahari Global Solutions @MatahariGlobal]

In our analysis of 14 countries, including DRC, Haiti, Madagascar & Somalia, we found communities unreached by COVID health information, no access to self-tests, unpaid health workers, & that 'vaccine hesitancy' claims are not nuanced. Access report here: https://t.co/MJXC4gNlmL

[Health Impact Fund @HealthImpact]

This is why the Health Impact Fund, which builds impact evaluation into its reward mechanism, is so special.

[Dr Agnes Soucat @asoucat]

Most evaluations in #globalhealth do not evaluate impact

[Health Impact Fund @HealthImpact]

@TakedaPharma's new #Dengue vaccine -- just approved in #Indonesia -- is an exciting step forward. But it should be made available at an accessible price everywhere it is needed. The @HealthImpact Fund is designed to make that happen.

[Health Impact Fund @HealthImpact]

If we want to encourage for-profit pharma companies to invest in diseases that primarily affect poor people (as Monkeypox used to be!) then we need to have a model that rewards them for it, not one that results in firms facing a huge financial penalty. Sustainability.

[Health Impact Fund @HealthImpact]

How broken is the system for supporting drug development for diseases mainly suffered by low-income people?

@GSK just got a contract for up to $170m million over 3 years for its novel malaria vaccine, Mosquirix. Enough to pay for production, maybe? https://t.co/e1kVKzsyLG

[Health Impact Fund @HealthImpact]

Bravo for GSK and partners including PATH and BMGF! Mosquirix is a tremendous step forward in parasite vaccine development. But this is not a step forward to having a sustainable system of drug development focusing on the needs of poor people.